INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD reported 1 transaction at LYELL IMMUNOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/28/2026ACC: 0001140361-26-029817
→
10% Owner
Since Jun 2026
-44K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−44K
Price / share
—
Trade value
—
% of position
1.6%
7/27/2026
2.82M→2.77M
Total
Net shares
−44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/27/2026 | J · J | −44K | — | — | 1.6% | 2.82M | 2.77M |
| Total | −44K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported